Status:
COMPLETED
Development of Serologic Assays for Human Herpes Virus-8
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Conditions:
Kaposi Sarcoma
HIV Infection
Eligibility:
All Genders
18-99 years
Brief Summary
Dr. Burbelo and colleagues have developed a technique for rapidly and quantitatively detecting antibody responses in sera to a variety of pathogens using recombinant proteins. We would like to apply t...
Detailed Description
Our colleagues have developed a technique for rapidly and quantitatively detecting antibody responses in sera to a variety of antigens using recombinant proteins. We would like to apply this technique...
Eligibility Criteria
Inclusion
- Data analysis only
Exclusion
Key Trial Info
Start Date :
October 30 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2020
Estimated Enrollment :
394 Patients enrolled
Trial Details
Trial ID
NCT00395278
Start Date
October 30 2006
End Date
December 10 2020
Last Update
December 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States, 20892